Tricida Inc TCDA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 09/24/21 EDT
4.43quote price arrow down-0.04 (-0.89%)
Volume
110,801
52 week range
3.55 - 9.81
Loading...
  • Open4.46
  • Day High4.64
  • Day Low4.40
  • Prev Close4.47
  • 52 Week High9.81
  • 52 Week High Date10/06/20
  • 52 Week Low3.55
  • 52 Week Low Date07/30/21

Key Stats

  • Market Cap223.40M
  • Shares Out50.43M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change-37.16

KEY STATS

  • Open4.46
  • Day High4.64
  • Day Low4.40
  • Prev Close4.47
  • 52 Week High9.81
  • 52 Week High Date10/06/20
  • 52 Week Low3.55
  • 52 Week Low Date07/30/21
  • Market Cap223.40M
  • Shares Out50.43M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change-37.16

RATIOS/PROFITABILITY

  • EPS (TTM)-4.37
  • P/E (TTM)-1.01
  • Fwd P/E (NTM)-1.77
  • EBITDA (MRQ)-191.762M
  • ROE (MRQ)-165.04%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)352.00%

EVENTS

  • Earnings Date11/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Tricida Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Tricida, Inc. is a late-stage pharmaceutical company focused on the discovery and clinical development of non-absorbed therapeutics to address renal, metabolic and cardiovascular disease. The Company's lead program, TRC101 is a treatment for chronic kidney disease (CKD). The Company is engaged in developing a non-absorbed drug to enable safety and efficacy for chronic treatment of CKD patients. The TRC101 drug acts in the gastrointestinal tract and clears the human body...
Klaus Veitinger M.D., Ph.D.
Non-Executive Chairman
Gerrit Klaerner Ph.D.
President
Geoffrey Parker
Chief Financial Officer
Robert Mckague Esq.
Executive Vice President
Dawn Parsell Ph.D.
Executive Vice President
Address
7000 Shoreline Ct Ste 201
South San Francisco, CA
94080-7603
United States

Top Peers

SYMBOLLASTCHG%CHG
TNXP
Tonix Pharmaceuticals Holding Corp
0.6063-0.0197-3.147%
ENLV
Enlivex Therapeutics Ltd
11.12-0.26-2.28%
ASLN
Aslan Pharmaceuticals Ltd
3.25+0.01+0.31%
CRVS
Corvus Pharmaceuticals Inc
6.80-0.23-3.27%
IMUX
Immunic Inc
9.22-0.30-3.15%